Inhibition of transformation of normal lymphocytes by plasma factor from patients with Hodgkin's disease and cancer.
D001798:Blood Proteins / Q000494:pharmacology*; D002850:Chromatography, Gel; D006689:Hodgkin Disease / Q000097:blood*; D006801:Humans; D066298:In Vitro Techniques; D008213:Lymphocyte Activation / Q000187:drug effects*; D009369:Neoplasms / Q000097:blood*
D001798:Blood Proteins